Skip to main content

Hyperemia

3
Pipeline Programs
1
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
2
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Bausch Health
Bausch HealthQUEBEC, Quebec, Canada
3 programs
1
2
Brimonidine TartratePhase 31 trial
Brimonidine TartratePhase 31 trial
Brimonidine tartratePhase 11 trial
Active Trials
NCT02039765Completed12Est. Apr 2014
NCT01959243Completed507Est. Jun 2014
NCT01959230Completed60Est. Dec 2013

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Bausch HealthBrimonidine Tartrate
Bausch HealthBrimonidine Tartrate
Bausch HealthBrimonidine tartrate

Clinical Trials (3)

Total enrollment: 579 patients across 3 trials

NCT01959243Bausch HealthBrimonidine Tartrate

Safety of Brimonidine Tartrate Ophthalmic Solution in a Population of Pediatric, Adult, and Geriatric Participants

Start: Feb 2014Est. completion: Jun 2014507 patients
Phase 3Completed
NCT01959230Bausch HealthBrimonidine Tartrate

Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution in Adult and Geriatric Participants With Ocular Redness

Start: Nov 2013Est. completion: Dec 201360 patients
Phase 3Completed
NCT02039765Bausch HealthBrimonidine tartrate

Pharmacokinetics and Safety of Topical Administration of Brimonidine Tartrate Ophthalmic Solution 0.025%.

Start: Feb 2014Est. completion: Apr 201412 patients
Phase 1Completed

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 late-stage (Phase 3) programs, potential near-term approvals
1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.